In the present study, a negative correlation was demonstrated between ING5 mRNA expression and the overall or progression-free survival time of the patients with Grade 2, Grade 3, and stage I cancer, but there was a negative association of ING5 mRNA expression with local invasion and clinical staging. This evidence concerns the gene ING5 and cancer.